Enterovirus Infections: Clinical Trials

107 trials for Enterovirus Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

82 completed, 15 unknown, 3 not yet recruiting, 3 withdrawn. 107 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4107Completed 82, Unknown 15, Not yet recruiting 3, Withdrawn 3, Recruiting 2, Active not recruiting 1, Terminated 1

Follow Enterovirus Infections: new trials by email Literature Review of Enterovirus Infections trials Research Report on Enterovirus Infections

Trials (filtered) newest first · largest first

All 107 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine
2wIPV+1sIPV, 1wIPV+2sIPV, 3wIPV - Poliomyelitis
Phase 4RecruitingSinovac Biotech Co., Ltd4802025-11-272026-03-09
Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations
sIPV, DTaP-IPV-Hib - Poliomyelitis
Phase 4RecruitingSinovac Biotech Co., Ltd1802025-09-262026-01-21
Study of Concomitant Administration of the sIPV and DTaP or MMR
sIPV, DTaP, bOPV 1,3 - Polio, Diphteria, Tetanus and Pertussis
Phase 4Not yet recruitingInstitute of Medical Biology, Chinese Academy of Medical Sciences26402025-05-152025-04-17
Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)
Pentavalent vaccine, Hexavalent vaccine, Inactivated poliovirus vaccine (IPV) - Polio
Phase 4Not yet recruitingInternational Centre for Diarrhoeal Disease Research, Bangladesh11902025-01-282024-12-27
Booster Dose of sIPV Co-administered With MMR and HepA-I.
sIPV, MMR, HepA-I - Poliomyelitis
Phase 4CompletedSinovac Biotech Co., Ltd8892024-08-082026-01-16
Phase IV Study of Concomitant Administration of the sIPV and HepA
sIPV (booster dose at 18 months of age), HepA-L, HepA-I - Polio, Hepatitis A
Phase 4Not yet recruitingInstitute of Medical Biology, Chinese Academy of Medical Sciences20002024-06-152024-06-14
Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufacturers
sIPV - Poliomyelitis
Phase 4CompletedSinovac Biotech Co., Ltd2002024-05-202025-03-14
Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosis
HAVRIX - Cirrhosis, Hep A
Phase 4UnknownMahidol University502024-02-292024-03-19
Persistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination.
Hepatitis A Vaccine - Hepatitis A
Phase 4UnknownBest Healthcare Inc.3002024-01-012023-12-28
Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People
2 doses of HAV, At least one dose of HAV - Hepatitis A, Immunodeficiency
Phase 4CompletedLiuZhou People's Hospital3922023-12-192025-12-31
Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine
EV71 Vaccine - Hand, Foot and Mouth Disease
Phase 4UnknownInstitute of Medical Biology, Chinese Academy of Medical Sciences15002023-11-252024-01-03
A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2
nOPV2 - Poliomyelitis
Phase 4CompletedFidec Corporation5012023-11-092026-09-03
Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), bOPV and IPV
polio vaccines: nOPV2, bOPV, IPV - Polio
Phase 4UnknownInternational Centre for Diarrhoeal Disease Research, Bangladesh8802023-11-012023-11-07
Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old
Healive (hepatitis A vacine(human diploid cell), inactivated) - Hepatitis A
Phase 4Active not recruitingSinovac Biotech Co., Ltd10922023-10-242024-08-21
An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)
Experimental Vaccine, Control Vaccine - Hand, Foot and Mouth Disease
Phase 4UnknownSinovac Biotech Co., Ltd4742022-07-302022-06-10
Assessing Immunogenicity of Intramuscular Sabin Inactivated Poliovirus Vaccine and Non-inferiority of Intradermal Fractional Inactivated Poliovirus Vaccine
Full dose Sabin Inactivated Poliovirus Vaccine produced by IMBCAMS, Fractional (1/5) Dose Sabin Inactivated Poliovirus Vaccine produced by IMBCAMS, Full dose Sabin Inactivated Poliovirus Vaccine produced by BIBP - Poliomyelitis
Phase 4CompletedCenters for Disease Control and Prevention12242022-07-262025-03-19
A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants
sIPV vaccine /DTaP vaccine, sIPV vaccine /Hepatitis A inactivated vaccine /MMR vaccine - Poliomyelitis
Phase 4CompletedSinovac Biotech Co., Ltd32002022-06-132023-01-12
Evaluation of Persistence of Immunity in 4-year-old Children Previously Immunised With IPV-Al AJV (Picovax®)
IPV-Al - Poliomyelitis
Phase 4CompletedAJ Vaccines A/S1632020-11-202021-06-22
Immunogenicity and Safety of the Booster Dose of Polio Vaccine With Different Primary Sequential Schedules in China
vaccinated with Sabin IPV, vaccinated with bOPV - Polio, Vaccine Reaction
Phase 4CompletedZhejiang Provincial Center for Disease Control and Prevention3872020-11-052022-03-07
Immunogenicity of Intramuscular and Intradermal IPV
fIPV (0.1 mL) ID, fIPV (0.1mL) IM, fIPV (0.2mL) IM - Poliomyelitis
Phase 4TerminatedCenters for Disease Control and Prevention9582019-10-062022-05-18

Showing 20 of 107. Sign in to see all of them.

Narrower conditions

Poliomyelitis (59)  ·  Hepatitis A (32)  ·  Tetanus (20)  ·  Diphtheria (19)  ·  Hand, Foot and Mouth Disease (15)  ·  Hepatitis B (14)  ·  Whooping Cough (12)  ·  Haemophilus Infections (8)  ·  Hepatitis (3)  ·  Measles (3)  ·  Chickenpox (2)  ·  Mumps (2)  ·  Rubella (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Colitis, Ulcerative (1)

Broader conditions

Picornaviridae Infections (107)  ·  RNA Virus Infections (107)  ·  Virus Diseases (107)  ·  Infections (106)  ·  Central Nervous System Diseases (59)  ·  Central Nervous System Infections (59)  ·  Myelitis (59)  ·  Nervous System Diseases (59)  ·  Neuroinflammatory Diseases (59)  ·  Neuromuscular Diseases (59)  ·  Spinal Cord Diseases (59)  ·  Digestive System Diseases (37)  ·  Hepatitis, Viral, Human (37)  ·  Liver Diseases (37)

Interventions

Hepatitis A Vaccines (18)  ·  Poliovirus Vaccine, Inactivated (7)  ·  Blood Specimen Collection (6)  ·  Engerix-B (5)  ·  Tetanus Toxoid (5)  ·  Aging (4)  ·  Hepatitis B Vaccines (4)  ·  twinrix (4)  ·  Measles-Mumps-Rubella Vaccine (3)  ·  Pentavac (3)  ·  RIX4414 vaccine (3)  ·  Diphtheria-Tetanus-acellular Pertussis Vaccines (2)  ·  Poliovirus Vaccine, Oral (2)  ·  diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (2)  ·  Chickenpox Vaccine (1)

Sponsors

GlaxoSmithKline (21)  ·  Sinovac Biotech Co., Ltd (16)  ·  Sanofi Pasteur, a Sanofi Company (10)  ·  Centers for Disease Control and Prevention (8)  ·  Institute of Medical Biology, Chinese Academy of Medical Sciences (7)  ·  Aga Khan University (4)  ·  Fidec Corporation (4)  ·  Jiangsu Province Centers for Disease Control and Prevention (4)  ·  Sanofi (4)  ·  International Centre for Diarrhoeal Disease Research, Bangladesh (3)  ·  Zhejiang Provincial Center for Disease Control and Prevention (3)  ·  Centers for Disease Control and Prevention, China (2)  ·  China National Biotec Group Company Limited (2)  ·  Chinese Academy of Medical Sciences (2)  ·  AJ Vaccines A/S (1)

Countries

China (42)  ·  Bangladesh (9)  ·  Belgium (9)  ·  Czechia (6)  ·  Germany (5)  ·  Canada (4)  ·  Pakistan (4)  ·  Finland (3)  ·  Italy (3)  ·  Thailand (3)  ·  Australia (2)  ·  France (2)  ·  India (2)  ·  Norway (2)  ·  Panama (2)

Top investigators

Fubao Ma (2)  ·  Xuhua Guan, M.S. (2)  ·  AIqiang Xu (1)  ·  Ali F Saleem, MBBS, MCR, FCPS (1)  ·  Ali F Saleem, MBBS,FCPS,MSc (1)  ·  Ali Saleem (1)  ·  Anita K.M Zaidi, MBBS, SM (1)  ·  Brian McMahon (1)  ·  Chien-Ching Hung (1)  ·  Christine H Lee, MD (1)  ·  Concepcion Estivariz, MD (1)

Results publications

PMID 32710245, PMID 21366801, PMID 24508042, PMID 26190091, PMID 33487470, PMID 11855555, PMID 16708058, PMID 17259872, PMID 20448468, PMID 20616762, PMID 20630640, PMID 22537990, PMID 23077849, PMID 24284413, PMID 25882172, PMID 25969561, PMID 26318714, PMID 26407255, PMID 27105563, PMID 27212429, PMID 27364568, PMID 28060048, PMID 28444156, PMID 28455172, PMID 28495264, PMID 28507927, PMID 28887164, PMID 29477307, PMID 29571817, PMID 30144521, PMID 30376086, PMID 30891604, PMID 31104832, PMID 31282539, PMID 31734699, PMID 31776027, PMID 31977278, PMID 32067817, PMID 32307279, PMID 32442523, PMID 32621741, PMID 32798224, PMID 33110280, PMID 33303216, PMID 33612341, PMID 34222044, PMID 35575051, PMID 35575974, PMID 35961362, PMID 36064670

NIH funding

2014 (2), 2015 (1)